199 related articles for article (PubMed ID: 19958895)
1. Effectiveness of ribavirin and corticosteroids for severe acute respiratory syndrome.
Lau EH; Cowling BJ; Muller MP; Ho LM; Tsang T; Lo SV; Louie M; Leung GM
Am J Med; 2009 Dec; 122(12):1150.e11-21. PubMed ID: 19958895
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
[TBL] [Abstract][Full Text] [Related]
3. The use of corticosteroids in SARS.
Oba Y
N Engl J Med; 2003 May; 348(20):2034-5; author reply 2034-5. PubMed ID: 12748321
[No Abstract] [Full Text] [Related]
4. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.
Muller MP; Dresser L; Raboud J; McGeer A; Rea E; Richardson SE; Mazzulli T; Loeb M; Louie M;
Pharmacotherapy; 2007 Apr; 27(4):494-503. PubMed ID: 17381375
[TBL] [Abstract][Full Text] [Related]
5. A cluster of cases of severe acute respiratory syndrome in Hong Kong.
Tsang KW; Ho PL; Ooi GC; Yee WK; Wang T; Chan-Yeung M; Lam WK; Seto WH; Yam LY; Cheung TM; Wong PC; Lam B; Ip MS; Chan J; Yuen KY; Lai KN
N Engl J Med; 2003 May; 348(20):1977-85. PubMed ID: 12671062
[TBL] [Abstract][Full Text] [Related]
6. Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong.
Chiu WK; Cheung PC; Ng KL; Ip PL; Sugunan VK; Luk DC; Ma LC; Chan BH; Lo KL; Lai WM
Pediatr Crit Care Med; 2003 Jul; 4(3):279-83. PubMed ID: 12831407
[TBL] [Abstract][Full Text] [Related]
7. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality.
Dokuzoguz B; Celikbas AK; Gök ŞE; Baykam N; Eroglu MN; Ergönül Ö
Clin Infect Dis; 2013 Nov; 57(9):1270-4. PubMed ID: 23946218
[TBL] [Abstract][Full Text] [Related]
8. [Severe acute respiratory syndrome: a singular epidemic of viral pneumonia].
Guihot A; Bricaire F; Li T; Bossi P
Presse Med; 2004 Mar; 33(5):344-51. PubMed ID: 15041887
[TBL] [Abstract][Full Text] [Related]
9. A major outbreak of severe acute respiratory syndrome in Hong Kong.
Lee N; Hui D; Wu A; Chan P; Cameron P; Joynt GM; Ahuja A; Yung MY; Leung CB; To KF; Lui SF; Szeto CC; Chung S; Sung JJ
N Engl J Med; 2003 May; 348(20):1986-94. PubMed ID: 12682352
[TBL] [Abstract][Full Text] [Related]
10. The influence of prehospital systemic corticosteroid use on development of acute respiratory distress syndrome and hospital outcomes.
Karnatovskaia LV; Lee AS; Gajic O; Festic E;
Crit Care Med; 2013 Jul; 41(7):1679-85. PubMed ID: 23660730
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.
Liu J; Zhang S; Dong X; Li Z; Xu Q; Feng H; Cai J; Huang S; Guo J; Zhang L; Chen Y; Zhu W; Du H; Liu Y; Wang T; Chen L; Wen Z; Annane D; Qu J; Chen D
J Clin Invest; 2020 Dec; 130(12):6417-6428. PubMed ID: 33141117
[TBL] [Abstract][Full Text] [Related]
12. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study.
Al-Tawfiq JA; Momattin H; Dib J; Memish ZA
Int J Infect Dis; 2014 Mar; 20():42-6. PubMed ID: 24406736
[TBL] [Abstract][Full Text] [Related]
13. Critical care lessons from severe acute respiratory syndrome.
Lapinsky SE; Granton JT
Curr Opin Crit Care; 2004 Feb; 10(1):53-8. PubMed ID: 15166850
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus-associated acute respiratory illness in adult non-immunocompromised patients: Outcomes, determinants of outcomes, and the effect of oral ribavirin treatment.
Wongsurakiat P; Sunhapanit S; Muangman N
Influenza Other Respir Viruses; 2022 Jul; 16(4):767-779. PubMed ID: 35150065
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic treatment of SARS: current knowledge and recommendations.
Tai DY
Ann Acad Med Singap; 2007 Jun; 36(6):438-43. PubMed ID: 17597972
[TBL] [Abstract][Full Text] [Related]
16. Management of severe acute respiratory syndrome: the Hong Kong University experience.
Tsang KW; Lam WK
Am J Respir Crit Care Med; 2003 Aug; 168(4):417-24. PubMed ID: 12912734
[No Abstract] [Full Text] [Related]
17. Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids.
Jones BM; Ma ES; Peiris JS; Wong PC; Ho JC; Lam B; Lai KN; Tsang KW
Clin Exp Immunol; 2004 Mar; 135(3):467-73. PubMed ID: 15008980
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.
Pelaez A; Lyon GM; Force SD; Ramirez AM; Neujahr DC; Foster M; Naik PM; Gal AA; Mitchell PO; Lawrence EC
J Heart Lung Transplant; 2009 Jan; 28(1):67-71. PubMed ID: 19134533
[TBL] [Abstract][Full Text] [Related]
19. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.
Yip TC; Lui GC; Wong VW; Chow VC; Ho TH; Li TC; Tse YK; Hui DS; Chan HL; Wong GL
Gut; 2021 Apr; 70(4):733-742. PubMed ID: 32641471
[TBL] [Abstract][Full Text] [Related]
20. Ribavirin therapy for severe COVID-19: a retrospective cohort study.
Tong S; Su Y; Yu Y; Wu C; Chen J; Wang S; Jiang J
Int J Antimicrob Agents; 2020 Sep; 56(3):106114. PubMed ID: 32712334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
